Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 I. Concept and diagnosis of autoimmune pancreatitis

详细信息    查看全文

• 作者：Kazuichi Okazaki (1)
  Shigeyuki Kawa (2)
  Terumi Kamisawa (3)
  Tetsuhide Ito (4)
  Kazuo Inui (5)
  Hiroyuki Irie (6)
  Takayoshi Nishino (7)
  Kenji Notohara (8)
  Isao Nishimori (9)
  Shigeki Tanaka (10)
  Toshimasa Nishiyama (11)
  Koichi Suda (12)
  Keiko Shiratori (13)
  Masao Tanaka (14)
  Tooru Shimosegawa (15)
  
• 关键词：Autoimmune pancreatitis ; Guideline ; Diagnosis ; Treatment ; Delphi method
• 刊名：Journal of Gastroenterology
• 出版年：2014
• 出版时间：April 2014
• 年：2014
• 卷：49
• 期：4
• 页码：567-588
• 全文大小：
• 参考文献：1. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561鈥?. CrossRef
  2. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732鈥?. CrossRef
  3. Japan Pancreas Society.Clinical diagnostic criteria for autoimmune pancreatitis.Suizo 2002; 17:585鈥?.
  4. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006;41:626鈥?1. CrossRef
  5. Members of the Autoimmune Pancreatitis Diagnostic Criteria Committee, the Research Committee of Intractable Diseases of the Pancreas supported by the Japanese Ministry of Health, Labour and Welfare, and Members of the Autoimmune Pancreatitis Diagnostic Criteria Committee, the Japan Pancreas Sociey. Clinical diagnostic criteria of autoimmune pancreatitis 2006. Suizo. 2006;21:395鈥?. (In Japanese with English abstract).
  6. Okazaki K, Kawa S, Kamisawa T, et al. Japanese consensus guidelines for management of聽autoimmune聽pancreatitis: I. Concept and diagnosis of聽autoimmune聽pancreatitis. J Gastroenterol. 2010;45:249鈥?5. CrossRef
  7. Kawa S, Okazaki K, Kamisawa T, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol. 2010;45(4):355鈥?9. CrossRef
  8. Kamisawa T, Okazaki K, Kawa S, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol. 2010;45(5):471鈥?. CrossRef
  9. Shimosegawa T, Chari ST, Frulloni L, et al. International Consensus Diagnostic Criteria for Autoimmune Pancreatitis: Guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352鈥?. CrossRef
  10. The Japan Pancreas Society, the Ministry of Health and Welfare Investigation Research Team for Intractable Pancreatic Disease. Suizo 2012; 27:17鈥?5. (In Japanese with English abstract).
  11. Shimosegawa T, et al. The amendment of the Clinical Diagnostic Criteria in Japan (JPS2011) in response to the proposal of the International Consensus of Diagnostic Criteria (ICDC) for聽autoimmune聽pancreatitis. Pancreas. 2012;41:1341鈥?. CrossRef
  12. Fitch K, Bernstein SJ, Aguilar MD, et al. The RAND/UCLA appropriateness method user鈥檚 manual. Santa Monica: RAND; 2001.
  13. U.S. Preventive Services Task Force http://www.ahrq.gov/clinic/3rduspstf/ratings.htm.
  14. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982鈥?. CrossRef
  15. Yamamoto M, Takahashi H, Ohara M, et al. A new conceptualization for Mikulicz鈥檚 disease as an IgG4-related plasmacytic disease. Mod Rheumatol. 2006;16:335鈥?0. CrossRef
  16. Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multi-organ lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68:1310鈥?. CrossRef
  17. Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22:1鈥?4. CrossRef
  18. Stone JH, Khosroshahi A, Deshpande V, et al. IgG4-Related disease: recommendations for the nomenclature of this condition and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061鈥?. CrossRef
  19. Okazaki K, Uchida K, Koyabu M, et al. Recent advances in the concept and diagnosis of聽autoimmune聽pancreatitis聽and IgG4-related disease. J Gastroenterol. 2011;46:277鈥?8. CrossRef
  20. Okazaki K, Uchida K, Ikeura T, et al. Current concept and diagnosis of IgG4-related disease in the hepato-bilio-pancreatic system. J Gastroenterol. 2013;48:303鈥?4. CrossRef
  21. Kawaguchi K, Koike M, Tsuruta K, et al. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant primary sclerosing cholangitis extensively involving pancreas. Hum Pahtol. 1991;22:387鈥?5.
  22. Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003;27:1119鈥?7. CrossRef
  23. Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004;445:552鈥?3. CrossRef
  24. Kl枚ppel G, Detlefsen S, Chari ST, et al. Autoimmune聽pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J Gastroenterol. 2010;45:787鈥?3. CrossRef
  25. Kamisawa T, Okamoto A, Funata N. Clinicopathological features of autoimmune pancreatitis in relation to elevation of serum IgG4. Pancreas. 2005;31:28鈥?1. CrossRef
  26. Kamisawa T, Wakabayashi T, Sawabu N. Autoimmune pancreatitis in young patients. J Clin Gastroenterol. 2006;40:847鈥?0. CrossRef
  27. Kawa S, Hamano H. Clinical features of autoimmune pancreatitis. J Gastroenterol. 2007;42(Suppl 18):9鈥?4. CrossRef
  28. Uchida K, Okazaki K, Konishi Y, et al. Clinical analysis of autoimmune-related pancreatitis. Am J Gastroenterol. 2000;95:2788鈥?4. CrossRef
  29. Nagata M, Yoshino J, Inui K, et al. A case of autoimmune pancreatitis following acute pancreatitis associated with septicemia. Suizo. 2003;18:215鈥?0.
  30. Sumida A, Kanemasa K, Tachibana S, et al. A case of autoimmune pancreatitis occurring during intravesical / Bacillus Calmette Guerin immunotherapy for ureteral cancer. Jpn J Gastroenterol. 2003;100:1328鈥?2.
  31. Kanno A, Nishimori I, Masamune A, et al. Nationwide epidemiological survey of聽autoimmune聽pancreatitis聽in Japan. Pancreas. 2012;41(6):835鈥?. CrossRef
  32. Okazaki K, Uchida K, Ohana M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology. 2000;118:573鈥?1. CrossRef
  33. Okazaki K. Autoimmune pancreatitis: etiology, pathogenesis, clinical findings and treatment. The Japanese experience. JOP. 2005;6(1 Suppl):89鈥?6.
  34. Shigeyuki K, Hideaki H. Serological markers for the diagnosis of autoimmune pancreatitis. Suizo. 2007;22:641鈥? (In Japanese with English abstract). CrossRef
  35. Nishimori I, Tamakoshi A, Kawa S, et al. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan. Pancreas. 2006;32:244鈥?. CrossRef
  36. Zen Y, Fujii T, Harada K, et al. Th2聽and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45:1538鈥?6. CrossRef
  37. Tanaka A, Moriyama M, Nakashima H, et al. Th2聽and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. Arthritis Rheum. 2012;64:254鈥?3. CrossRef
  38. Kamisawa T, Egawa N, Inokuma S, et al. Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas. 2003;27:235鈥?. CrossRef
  39. Nishino T, Toki F, Oyama H, et al. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med. 2006;45:497鈥?01. CrossRef
  40. Ito T, Nishimori I, Inoue N, et al. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol. 2007;42(Suppl 18):50鈥?. CrossRef
  41. Tanaka S, Kobayashi T, Nakanishi K, et al. Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis. Lancet. 2000;356:910鈥?. CrossRef
  42. Ko SB, Mizuno N, Yatabe Y, et al. Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. Gastroenterology. 2010;138(5):1988鈥?6. CrossRef
  43. Yoda Y, Kobayashi K, Enomoto N. Study of category classification in abdominal ultrasonographic mass screening. J Gastroenterol Mass Surv. 2006;44:12鈥?0.
  44. Irie H, Ito T. US, CT and MRI findings of autoimmune pancreatitis based on 鈥淐linical diagnostic criteria of autoimmune pancreatitis 2006鈥? Suizo. 2007;22:629鈥?3 (In Japanese with English abstract). CrossRef
  45. Kamisawa T, Egawa N, Nakajima H, et al. Comparison of radiological and histological findings in autoimmune pancreatitis. Hepatogastroenterol. 2006;53(72):953鈥?.
  46. Muraki T, Ozaki Y, Hamano H, et al. Ultrasonographic diagnosis of autoimmune pancreatitis. Biliary Tract Pancreas. 2005;26:711鈥?.
  47. Honjo H, Takeuchi K, Nagashima N, et al. Biliary duct lesions associated with autoimmune pancreatitis. Biliary Tract Pancreas. 2001;22:581鈥?.
  48. Hyodo N, Hyodo T. Ultrasonographic evaluation in patients with autoimmune-related pancreatitis. J Gastroenterol. 2003;38(12):1155鈥?1. CrossRef
  49. Hasebe O, Arakura N, Imai Y, et al. The findings of ERC and IDUS in autoimmune pancreatitis. J Gastroenterol Imaging. 2002;4:41鈥?.
  50. Nagase M, Furuse J, Ishii H, et al. Evaluation of contrast enhancement patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent. J Ultrasound Med. 2003;22(8):789鈥?5.
  51. Numata K, Ozawa Y, Kobayashi N, et al. Contrast-enhanced sonography of autoimmune pancreatitis: comparison with pathologic findings. J Ultrasound Med. 2004;23(2):199鈥?06.
  52. Miyoshi H, Inui K, Yoshino J, et al. Usefulness of contrast-enhanced ultrasonography in autoimmune pancreatitis. Suizo. 2010;25:117鈥?4 (In Japanese with English abstract). CrossRef
  53. Irie H, Honda H, Baba S, et al. Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol. 1998;170:1323鈥?. CrossRef
  54. Sahani DV, Kalva SP, Farrell J, et al. Autoimmune pancreatitis: imaging features. Radiology. 2004;233:345鈥?2. CrossRef
  55. Suzuki K, Itoh S, Nagasaka T, et al. CT findings in autoimmune pancreatitis: assessment using multiphase contrast-enhanced multisection CT. Clin Radiol. 2010;65(9):735鈥?3. CrossRef
  56. Hirota M, Tsuda M, Tsuji Y, et al. Perfusion computed tomography findings of autoimmune pancreatitis. Pancreas. 2011;40(8):1295鈥?01. CrossRef
  57. Ishigami K, Tajima T, Nishie A, et al. MRI findings of pancreatic lymphoma and autoimmune pancreatitis: a comparative study. Eur J Radiol. 2010;74(3):e22鈥?. CrossRef
  58. Kamisawa T, Takuma K, Anjiki H, et al. Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol. 2010;105(8):1870鈥?. CrossRef
  59. Hur BY, Lee JM, Lee JE, et al. Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma. J Magn Reson Imaging. 2012;36(1):188鈥?7. CrossRef
  60. Muhi A, Ichikawa T, Motosugi U, et al. Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging. 2012;35(4):827鈥?6. CrossRef
  61. Horiuchi A, Kaneko T, Yamamura N, et al. Autoimmune chronic pancreatitis simulating pancreatic lymphoma. Am J Gastroenterol. 1996;91:2607鈥?.
  62. Saegusa H, Momose M, Kawa S, et al. Hilar and pancreatic gallium-67 accumulation is characteristic feature of autoimmune pancreatitis. Pancreas. 2003;27:20鈥?. CrossRef
  63. Higashi T, Saga T, Nakamoto Y, et al. Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) 鈥搖sefulness and limitations in 鈥渃linical reality鈥? Ann Nucl Med. 2003;17:261鈥?9. CrossRef
  64. Nakamoto Y, Sakahara H, Higashi T, et al. Autoimmune pancreatitis with F-18 fluoro-2-deoxy-d -glucose PET findings. Clin Nucl Med. 1999;24:778鈥?0. CrossRef
  65. Nakamoto Y, Saga T, Ishimori T, et al. FDG-PET of autoimmune-related pancreatitis: preliminary results. Eur J Nucl Med. 2000;27:1835鈥?. CrossRef
  66. Nakajo M, Jinnouchi S, Fukukura Y, et al. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging. 2007;34:2088鈥?5. CrossRef
  67. Ozaki Y, Oguchi K, Hamano H, et al. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol. 2008;43:144鈥?1. CrossRef
  68. Sato M, Okumura T, Shioyama Y, et al. Extrapancreatic F-18 FDG accumulation in autoimmune pancreatitis. Ann Nucl Med. 2008;22:215鈥?. CrossRef
  69. Nishimori I, Kohsaki T, Onishi S, et al. IgG4-related autoimmune prostatitis: two cases with or without autoimmune pancreatitis. Intern Med. 2007;46:1983鈥?. CrossRef
  70. Shigekawa M, Yamao K, Sawaki A, et al. Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis? J Hepatobiliary Pancreat Surg. 2009;17:269鈥?4. CrossRef
  71. Toki F, Kozu T, Oi I. An usual type of chronic pancreatitis showing diffuse narrowing of the entire main pancreatic duct on ERCP. A report of four cases. Endoscopy. 1992;24:640.
  72. Wakabayshi T, Kawamura Y, Satomura Y, et al. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation; comparison with so-called tumor-forming pancreatitis and pancreatic cancer. Am J Gastroenterol. 2003;98:2679鈥?7. CrossRef
  73. Nakazawa T, Ohara H, Sano H, et al. Difficulty in diagnosing autoimmune pancreatitis. Gastrointest Endosc. 2007;65:99鈥?08. CrossRef
  74. Nishino T, Oyama H, Toki F, et al. Differentiation between autoimmune pancreatitis and pancreatic carcinoma based on endoscopic retrograde cholangiopancreatography findings. J Gastroenterol. 2010;45:988鈥?6. CrossRef
  75. Kamisawa T, Imai M, Yui Chen P, et al. Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas 2008;37:e62鈥?.
  76. Kamisawa T, Tu Y, Egawa N, et al. Involvement of pancreatic and bile ducts in autoimmune pancreatitis. World J Gastroenterol. 2006;12:612鈥?.
  77. Ito T, Nakano I, Koyanagi S, et al. Autoimmune pancreatitis as a new clinical entity; three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci. 1997;42:1458鈥?8. CrossRef
  78. Horiuchi A, Kawa S, Hamano H, et al. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc. 2002;4:494鈥?. CrossRef
  79. Nishino T, Toki F, Oyama H, et al. Biliary tract involvement in autoimmune pancreatitis. Pancreas. 2005;30:76鈥?2.
  80. Nakazawa T, Ohara H, Sano H, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc. 2004;60:937鈥?4. CrossRef
  81. Hirano K, Shiratori Y, Komatsu Y, et al. Involvement of the biliary system in autoimmune pancreatitis: a follow-up study. Clin Gastroenterol Hepatol. 2003;1:453鈥?4. CrossRef
  82. Ectors N, Maillet B, Aerts R, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut. 1997;41:263鈥?. CrossRef
  83. Suda K, Takase M, Fukumura Y, et al. Histopathologic characteristics of autoimmune pancreatitis based on comparison with chronic pancreatitis. Pancreas. 2005;30:355鈥?. CrossRef
  84. Suda K, Nishimori I, Takase M, et al. Autoimmune pancreatitis can be classified into early and advanced stages. Pancreas. 2006;33:345鈥?0. CrossRef
  85. Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol. 2006;30:1537鈥?5. CrossRef
  86. Kojima M, Sipos B, Klapper W, et al. Autoimmune pancreatitis: frequency, IgG4 expression, and clonality of T and B cells. Am J Surg Pathol. 2007;31:521鈥?. CrossRef
  87. Aoki S, Nakazawa T, Ohara H, et al. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients鈥?sera. Histopathology. 2005;47:147鈥?8. CrossRef
  88. Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007;20:23鈥?. CrossRef
  89. Deshpande V, Zen Y, Chan JK, et al. Consensus statement of the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181鈥?2. CrossRef
  90. Mizuno N, Bhatia V, Hosoda W, et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol. 2009;44:742鈥?0. CrossRef
  91. Levy MJ, Reddy RP, Wiersema MJ, et al. EUS-guided trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice. Gastrointest Endosc. 2005;61:467鈥?2. CrossRef
  92. Imai K, Matsubayashi H, Fukutomi A, et al. Endoscopic ultrasonography-guided fine needle aspiration biopsy using 22-gauge needle in diagnosis of autoimmune pancreatitis. Dig Liver Dis. 2011;43:869鈥?4. CrossRef
  93. Kanno A, Ishida K, Hamada S, et al. Diagnosis of autoimmune pancreatitis by EUS-FNA by using a 22-gauge needle based on the International Consensus Diagnostic Criteria. Gastrointest Endosc. 2012;76:594鈥?02. CrossRef
  94. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol. 2006;4:1010鈥?. CrossRef
  95. Kim K, Kim MW, Kim JC, et al. Diagnostic criteria for autoimmune pancreatitis revisited. World J Gastroenterol. 2006;12:2487鈥?6.
  96. Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan鈥揔orea Symposium on Autoimmune Pancreatitis. J Gastroenterol. 2008;43:403鈥?. CrossRef
  97. Kamisawa T, Tu Y, Nakajima H, et al. Usefulness of biopsying the major duodenal papilla to diagnose autoimmune pancreatitis: a prospective study using IgG4-immunostaining. World J Gastroenterol. 2006;12:2031鈥?.
  98. Kubota K, Iida H, Fujisawa T, et al. Clinical significance of swollen duodenal papilla in聽autoimmune聽pancreatitis. Pancreas. 2007;35(4):e51鈥?0. CrossRef
  
• 作者单位：Kazuichi Okazaki (1)
  Shigeyuki Kawa (2)
  Terumi Kamisawa (3)
  Tetsuhide Ito (4)
  Kazuo Inui (5)
  Hiroyuki Irie (6)
  Takayoshi Nishino (7)
  Kenji Notohara (8)
  Isao Nishimori (9)
  Shigeki Tanaka (10)
  Toshimasa Nishiyama (11)
  Koichi Suda (12)
  Keiko Shiratori (13)
  Masao Tanaka (14)
  Tooru Shimosegawa (15)
  
  1. Department of Gastroenterology and Hepatology, Kansai Medical University, 2-3-1 Shinmachi, Hirakata, Osaka, 573-1191, Japan
  2. Center for Health, Safety and Environmental Management, Shinshu University, Matsumoto, Japan
  3. Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
  4. Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  5. Department of Gastroenterology, Second Teaching Hospital, Fujita Health University, Nagoya, Japan
  6. Department of Radiology, Faculty of Medicine, Saga University, Saga, Japan
  7. Department of Gastroenterology, Tokyo Women鈥檚 Medical University, Yachiyo Medical Center, Yachiyo, Japan
  8. Department of Anatomic Pathology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan
  9. Nishimori Clinic, Kochi, Japan
  10. Department of Acupuncture and Moxibusion, Tokyo Ariake University of Medical and Health Sciences, Tokyo, Japan
  11. Department of Public Health and Hygiene, Kansai Medical University, Osaka, Japan
  12. Department of Pathology, Tokyo-West Tokushukai Hospital, Tokyo, Japan
  13. Department of Gastroenterology, Tokyo Women鈥檚 Medical University, Tokyo, Japan
  14. Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  15. Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan
  
• ISSN：1435-5922

文摘

Background In response to the proposal of the international consensus diagnostic criteria (ICDC) for autoimmune pancreatitis (AIP) and the Japanese diagnostic criteria in 2011, the 2009 Japanese consensus guidelines for managing AIP required revision. Methods Three committees [the professional committee for making clinical questions (CQs) and statements by Japanese specialists, the expert panelist committee for rating statements by the modified Delphi method, and the evaluating committee by moderators] were organized. Fifteen specialists for AIP extracted the specific clinical statements from 1,843 articles published between 1963 and 2012 (obtained from Pub Med and a secondary database, and developed the CQs and statements. The expert panel individually rated the clinical statements using a modified Delphi approach, in which a clinical statement receiving a median score greater than seven on a nine-point scale from the panel was regarded as valid. Results The professional committee created 13 CQs and statements for the current concept and diagnosis of AIP, 6 for extra-pancreatic lesions, 6 for differential diagnosis, and 11 for treatment. Conclusion After evaluation by the moderators, amendments to the Japanese consensus guidelines for AIP have been proposed for 2013.